CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $48,000 | -97.9% | 26,841 | -93.3% | 0.00% | -100.0% |
| Q3 2020 | $2,332,000 | +2889.7% | 400,000 | +3357.5% | 0.02% | +1600.0% |
| Q2 2020 | $78,000 | -98.7% | 11,569 | -97.1% | 0.00% | -97.3% |
| Q2 2019 | $5,843,000 | -44.5% | 392,919 | -7.4% | 0.04% | -47.1% |
| Q1 2019 | $10,526,000 | -24.2% | 424,099 | -45.1% | 0.07% | -30.0% |
| Q4 2018 | $13,878,000 | -35.9% | 772,718 | +10.5% | 0.10% | +1.0% |
| Q3 2018 | $21,653,000 | -11.5% | 699,066 | +30.0% | 0.10% | -11.6% |
| Q2 2018 | $24,455,000 | -24.0% | 537,813 | -11.7% | 0.11% | -16.4% |
| Q1 2018 | $32,164,000 | +7.9% | 609,166 | +39.0% | 0.13% | +42.6% |
| Q4 2017 | $29,801,000 | -57.1% | 438,245 | -48.1% | 0.09% | -65.4% |
| Q3 2017 | $69,520,000 | +21.5% | 843,688 | +38.0% | 0.27% | +15.3% |
| Q2 2017 | $57,231,000 | -24.1% | 611,251 | -48.4% | 0.24% | -33.0% |
| Q1 2017 | $75,435,000 | +132.5% | 1,184,771 | +62.2% | 0.35% | +102.3% |
| Q4 2016 | $32,451,000 | -36.2% | 730,539 | -48.2% | 0.17% | -40.8% |
| Q3 2016 | $50,860,000 | +4842.7% | 1,410,826 | +1781.1% | 0.29% | +4100.0% |
| Q2 2016 | $1,029,000 | -96.8% | 75,000 | -91.8% | 0.01% | -96.8% |
| Q4 2015 | $31,857,000 | -28.3% | 910,204 | +88.3% | 0.22% | -32.6% |
| Q3 2015 | $44,443,000 | +667.4% | 483,281 | +633.4% | 0.33% | +811.1% |
| Q2 2015 | $5,791,000 | -64.1% | 65,900 | -69.7% | 0.04% | -72.3% |
| Q1 2015 | $16,139,000 | +114.1% | 217,414 | +30.8% | 0.13% | +124.1% |
| Q3 2014 | $7,538,000 | +177.3% | 166,176 | +153.2% | 0.06% | +87.1% |
| Q2 2014 | $2,718,000 | – | 65,643 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |